AMREP CORP. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AMREP CORP. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	42.4	8.93	12.8	18.8	40.1	58.9	48.7	51.4	49.7	52.8
Cost of revenue		6.06	10.8	13.3
Gross profit		2.87	2.06	5.48
General and administrative				13	5.42	5.35	5.47	6.87	7.28	9.03
Operating income			-3.23	-7.96	9.05	21.3	5.83	7.6	12.1	12.4
Interest expense	0.33	0.01	0.03
Other non-operating income									-0
Pre-tax income	0.98	3.46	-3.17	-7.63	10	21.6	7.64	8.43	13.7	14.1
Income tax	1	-0.28	-0.71	-1.72	2.64	5.7	-14.1	1.74	1.01	3.84
Income from continuing operations	-0.02	0.24
Net income	-0.02	0.24	1.53	-5.9	7.39	15.9	21.8	6.69	12.7	10.3
EBITDA			-2.62	-7.42	9.6	21.5	5.89	7.75	12.3	12.7
EPS, basic	0.00	0.03	0.19	-0.73	0.95	2.21	4.13	1.26	2.39	1.93
EPS, diluted	0.00	0.03	0.19	-0.73	0.95	2.21	4.11	1.25	2.37	1.91
Shares, basic (weighted)	8.05	0.01	0.01	0.01	0.01	0.01	0.01	5.3	5.32	5.34
Shares, diluted (weighted)	8.08	0.01	0.01	0.01	0.01	0.01	0.01	5.35	5.37	5.39

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	11.8	10.9	13.3	17.5	24.8	15.7	20	29.7	39.5	52.3
Short-term investments							0		0	0
Receivables	6.38	5.9							0	0
Property, plant and equipment	10.9	9.75		0.04	0.03	1.27	1.35	1.74	2.19	2.14
Lease right-of-use assets				0.11	0.08	0.12	0.09	0.07	0.04	0.14
Total assets	107	106	101	96.7	97.4	94.9	116	123	134	145
Total liabilities	21.8	19.1	10.7	12	8.48	11.8	4.9	4.78	3.82	4.14
Total debt				3.85	3.48	2.03	0.04	0.04	0.03	0.02
Paid-in capital	50.7	50.9	51.2	51.3	45.1	32.4	32.7	33	33.4	33.9
Retained earnings	47.3	47.5	49.1	43.1	47.7	54.8	76.6	83.3	96	106
Treasury stock	-4.22	-4.22	-4.22	-4.22	0
Other comprehensive income	-9.24	-7.93	-7.03	-6.47	-4.62	-4.57	1.17	1.23
Shareholders' equity	85.4	87.1	89.8	84.6	88.9	83.2	111	118	130	141
Total equity	85.4	87.1	89.8	84.6	88.9	83.2	111	118	130	141
Total liabilities and equity	107	106	101	96.7	97.4	94.9	116	123	134	145

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	-0.02	0.24	1.53	-5.9	7.39	15.9	21.8	6.69	12.7	10.3
Depreciation and amortization	1.4	1.25	0.61	0.54	0.55	0.23	0.06	0.15	0.18	0.31
Stock-based compensation	0.12	0.18	0.23	0.11	0.13	0.22	0.24	0.32	0.42	0.45
Deferred income tax	0.62	0.64	-0.3	-1.8	2.49	1.77	-13.8	1.46	0.84	3.2
Change in receivables	0.93	0.51
Change in payables	-1.42	1.37	0.2	0.16	1.29	1.49	-1.25	-0.04	-1.07	0.31
Cash from operations	10.4	0.53	0.59	0.77	12.6	15.5	6.39	10.7	10.2	12.9
Capital expenditures	-0.25	-0.05	-0.01	-0.01	-0.01	-1.29	-0.13	-0.46	-0.58	-0.1
Cash from investing	-0.25	-0.14	0.15	-0.01	-0.01	-1.2	-0.13	-0.46	-0.55	-0.1
Stock issued						-0.03
Share buybacks				0	-5.12	-21.9	0
Cash from financing	-12.9	1.84	-0.55	2.51	-5.31	-23.4	-1.99	-0.01	-0.01	-0.01
Net change in cash	-2.75	2.23	0.2	3.27	7.3	-9.08	4.27	10.2	9.68	12.8
Free cash flow	10.2	0.48	0.58	0.76	12.6	14.2	6.26	10.3	9.66	12.8
Interest paid	0.32	0.05	0.22	0.18	0.12	0.2	0.06	0
Income taxes paid	-0.14	0.01	-0.25	-0.15	0.15	0	0.13	0.31	0.32	0.5

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $22.37 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	14.8%	Operating income / revenue.
EBITDA margin	15.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	19.0%	Pre-tax income / revenue.
Net margin	14.3%	Net income / revenue.
FCF margin	-0.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-0.7%	Cash from operations / revenue.
Effective tax rate	24.8%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	4.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.0%	Net income / average total assets.
Return on invested capital (ROIC)	4.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	1.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.2%	Capital expenditures / revenue.
D&A / revenue	0.8%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	6.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	2.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	5.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	2.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	28.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	6.5%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	3.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	29.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	5.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-19.1%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-22.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	6.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-19.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-22.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	15.0%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	25.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	26.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	0.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	32.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	26.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	0.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	8.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	8.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	9.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	8.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	7.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	8.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	905.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	270.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Debt / equity	0.00x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	0.0%	Total debt / total assets.
Liabilities / assets	3.1%	Total liabilities / total assets.
Net debt	-$48.7M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-7.61x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Tangible book value	$141.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.28x	Revenue / average total assets.
Fixed asset turnover	19.4x	Revenue / average property, plant and equipment.
FCF conversion	-6.3%	Free cash flow / net income, when net income is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.09	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$7.61	Revenue / diluted weighted shares.
FCF per share	-$0.07	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$0.05	Cash from operations / diluted weighted shares.
Book value per share	$26.17	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$26.17	Tangible book value / shares outstanding.
Cash per share	$9.03	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$119.1M	Share price x shares outstanding.
Enterprise value	$70.4M	Market cap + total debt - cash - short-term investments.
P/E	20.3x	Market cap / net income. Only when net income is positive.
P/S	2.90x	Market cap / revenue.
P/B	0.84x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.84x	Market cap / tangible book value, when positive.
EV/Sales	1.72x	Enterprise value / revenue.
EV/EBIT	11.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.0x	Enterprise value / EBITDA, when both are positive.
FCF yield	-0.3%	Free cash flow / market cap.
Earnings yield	4.9%	Net income / market cap (the inverse of P/E).

What was AMREP CORP.'s revenue in fiscal 2026?

AMREP CORP. reported revenue of $52.8M for fiscal 2026, 6.3% higher than the year before.

Was AMREP CORP. profitable in fiscal 2026?

Yes. Net income was $10.3M, a net margin of 19.5%.

How much free cash flow did AMREP CORP. generate in fiscal 2026?

Cash from operations of $12.9M minus capital expenditures of $102.0K left free cash flow of $12.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AMREP CORP.